At-home hormone testing

Most consumer panels cover some combination of sex hormones, thyroid markers and cortisol. The exact list varies, and the sensible way to choose one is by what question you are trying to answer rather than by how many markers it counts.

Symptoms that people attribute to sex hormones very often turn out to be thyroid, iron status or sleep. A panel that covers only one group can send you down the wrong path confidently.

For anyone who menstruates, sex hormone results are close to meaningless without knowing where in the cycle the sample was taken. Oestradiol and progesterone both move substantially across a normal cycle, and the same value can be entirely expected on one day and notable on another.

Good services ask for cycle day and specify a collection window. A panel that does not ask is not going to be interpretable, however good its laboratory is.

Hormonal contraception changes the picture again, as do perimenopause and any hormone therapy already in use. Record all of it and hand it over with the results.

Blood spot testing is closest to what a clinical laboratory would run, and it is the format clinicians are most comfortable interpreting. Saliva and dried urine testing are used in this market too, and are more contested — some clinicians use them routinely, others will simply repeat everything in blood.

If your goal is a result a clinician will act on, blood is the pragmatic choice. Ask the service which laboratory runs the analysis and whether it is CLIA-certified.

A result outside a reference range is a prompt to investigate, not a conclusion. Reference ranges are population statistics, they differ between laboratories, and a single value taken at one moment does not establish a condition. This is the single most common way home testing goes wrong.

Direct-to-consumer testing that you buy yourself is generally not covered. Insurance ordinarily pays for testing ordered by a clinician for a documented clinical reason, and a kit you bought online does not meet that description.

• Testing ordered by your own clinician is usually the covered route, and often cheaper than a consumer panel.
• Some services can bill insurance where a clinician on their side orders the panel — ask before purchasing.
• HSA and FSA funds can frequently be used for consumer testing even where insurance will not pay directly.
• If a home result leads to a consultation, the follow-up testing your clinician orders is normally handled as ordinary covered care.

Worth knowing before you buy: asking your own clinician to order the panel is often both cheaper and more useful, because the result arrives with someone already positioned to interpret it.

Kits are marketed on breadth and on convenience, which are the two attributes least connected to whether the result will be useful. A shorter checklist works better.

• Which laboratory runs the assay, and is it accredited? The kit is packaging; the laboratory is the product.
• Does the kit specify when to collect, and does it explain why? For anything cycle-dependent or diurnal, a kit that lets you collect whenever is convenient has given up the thing that makes the result interpretable.
• Is the sample type appropriate to the analyte, or chosen because it posts well?
• Does a licensed clinician review the result, and are they licensed in your state?
• Is there a route onward if something is out of range, or does the service end at a PDF?
• What happens to your sample and your data afterwards, and can you have both deleted?

A bigger panel is not a better panel. Reference intervals are constructed so that a proportion of entirely healthy people fall outside them, so ordering more analytes without a reason reliably produces a flagged value that then has to be chased — sometimes with repeat testing, occasionally with imaging. That cost does not appear on the price you paid.

Most of the direct-to-consumer hormone market is aimed at women, and the cycle is the reason the marketing and the clinical reality diverge most sharply here.

Several of the hormones on a standard female panel vary substantially across a menstrual cycle rather than fluctuating mildly. A value drawn on the wrong day is not a slightly less accurate value — for some analytes it is uninterpretable without knowing the day it came from. Any panel that does not ask where you are in your cycle is discarding the information required to read its own result.

Hormonal contraception complicates this further, because it alters several of the measurements a panel reports. So does pregnancy, and so does the perimenopausal transition — which is precisely when many people go looking for a panel, and which is also when values move most.

This is why a home panel cannot establish menopausal status on its own. That determination is clinical, made on symptoms and pattern over time as much as on any single measurement, and it belongs to a provider rather than to a report.

Take the full report to a clinician along with a symptom record and your cycle information. The report on its own is a set of numbers; the value comes from someone reading them against your history.

How we verify providers

• NIH MedlinePlus — Hormone testing / laboratory tests — retrieved 2026-08-06
• NIH MedlinePlus — Growth Hormone Tests — retrieved 2026-08-06